Agree. There is great product potential here. But I align myself with a number of posters here today with the same question. What is the path to market? Lets hope "early Q3 2024" reveals this.
Ann: Further Significant Improvement in Rett Syndrome Patients, page-8
Add NTI (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.4¢ |
Change
-0.001(1.82%) |
Mkt cap ! $55.86M | |||
| Open | High | Low | Value | Volume |
| 5.5¢ | 5.5¢ | 5.3¢ | $44.13K | 814.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 13 | 3289722 | 5.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.5¢ | 253965 | 2 |
View Market Depth
| Last trade - 16.10pm 13/11/2024 (20 minute delay) ? |
| NTI (ASX) Chart |